Should dexamethasone be administered to a 5‑month‑old infant with bronchiolitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No, dexamethasone should not be given for bronchiolitis in a 5-month-old infant.

Corticosteroids, including dexamethasone, do not provide clinical benefit in bronchiolitis and should not be used. This is a strong recommendation based on high-quality evidence from the American Academy of Pediatrics (AAP) 2014 Clinical Practice Guideline 1.

Evidence Against Dexamethasone Use

The AAP guideline (aggregate evidence quality: A) explicitly states that corticosteroids:

  • Do not significantly reduce hospital admissions (pooled risk ratio 0.92; 95% CI 0.78-1.08)
  • Do not reduce length of hospital stay (mean difference -0.18 days; 95% CI -0.39 to 0.04)
  • Show no relevant differences in either primary or secondary outcomes 1

This conclusion is based on a Cochrane systematic review of 17 trials involving 2,596 participants, including two large emergency department-based randomized trials 1.

The Controversy Around Combination Therapy

One frequently cited study (the Canadian Bronchiolitis Epinephrine Steroid Trial) showed a potential reduction in hospitalizations when combining nebulized epinephrine with oral dexamethasone 1, 2. However:

  • The unadjusted analysis showed a relative risk of 0.65 (95% CI 0.45-0.95; P=0.02)
  • After adjustment for multiple comparisons, this result became statistically insignificant (P=0.07) 1, 2
  • The AAP guideline explicitly states that "a recommendation regarding the benefit of combined dexamethasone and epinephrine therapy is premature" 1

A 2017 meta-analysis of combination therapy confirmed no significant benefit: pooled data showed combination treatment was ineffective in reducing hospital admission and length of stay 3.

Safety Concerns

While short-term adverse effects appear minimal, the guideline notes:

  • Prolonged viral shedding has been documented with corticosteroid use
  • There is inadequate evidence to be certain of safety in infants with bronchiolitis 1

Clinical Bottom Line

For your 5-month-old patient with bronchiolitis:

  • Do not administer dexamethasone (alone or in combination with epinephrine)
  • Focus on supportive care measures
  • The evidence is clear and consistent across multiple high-quality studies that corticosteroids provide no meaningful clinical benefit

The FDA labeling for dexamethasone does not include bronchiolitis as an indication 4, and its use in this context represents off-label prescribing without supporting evidence.

References

2
Research

Epinephrine and dexamethasone in children with bronchiolitis.

The New England journal of medicine, 2009

Related Questions

In a 6-year-old with reactive airway disease and upper respiratory infection symptoms, PEWS score 3, who received dexamethasone and a duoneb an hour ago and still has retractions while on oxygen, what additional emergency department management should be initiated when starting high-flow nasal cannula?
In a 40‑day‑old infant with a probable viral upper respiratory infection, clear lung auscultation, and resolved dyspnea, should systemic steroids and nebulized therapy be administered?
Can dexamethasone (Decadron) be used for acute bronchitis?
What are the respiratory adverse effects associated with dexamethasone, listed from most common to least common?
What is the recommended dose and duration of a dexamethasone taper for an adult patient with bronchitis and no significant medical history?
What is the appropriate cefdinir dosing for a 3-year-old child with cellulitis?
What laboratory and imaging tests should be ordered to evaluate whether a patient with elevated cholesterol has thickened blood and atherosclerotic plaque?
Which test should be ordered to assess blood viscosity?
How long can Lantus (insulin glargine) cause hypoglycemia after an overdose?
In suspected hyperviscosity syndrome, are the activated partial thromboplastin time (aPTT) and fibrinogen levels typically normal?
When abdominal pain is reproduced by palpation in a gassy patient, does this suggest the pain is due to intestinal gas rather than an inflammatory or ischemic cause?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.